查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1808335

多重檢測市場（按產品類型、檢測類型、應用和最終用戶）—2025-2030 年全球預測

Multiplex Assays Market by Product Type, Assay Type, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

多重檢測市場預計到 2024 年將達到 28.1 億美元，到 2025 年將達到 31 億美元，到 2030 年將達到 51.6 億美元，複合年成長率為 10.67%。

主要市場統計數據
基準年2024年 28.1億美元
預計2025年 31億美元
預測年份 2030 51.6億美元
複合年成長率（%） 10.67%

定位多重分析：平台整合與效能最佳化的創新推動現代分析格局

多重檢測因其能夠同時檢測單一樣本基質中的多種分析物，已成為生物分析和診斷工作流程的基礎技術。隨著研究人員和臨床醫生尋求在更短的時間內獲得更全面的資料集，將先進檢測模式與自動化分析流程相結合的平台正迅速普及。在微流體、奈米技術和高通量儀器融合的推動下，該領域如今支持著廣泛的應用，從免疫療法試驗中的細胞激素分析到照護現場的病原體篩檢。

透過整合、小型化和數據分析揭示影響多重檢測市場的關鍵變革

多重檢測市場正在經歷重大變革，其特點是三個相互關聯的動態：平台整合、小型化和增強的數據分析。雖然檢測開發人員最初專注於獨立的檢測技術，但最近的趨勢傾向於結合螢光、發光和質譜的整合平台。這種轉變使實驗室能夠整合工作流程，減少樣品消費量，並透過在一台儀器上利用互補的檢測模式來加快獲得結果的時間。

評估 2025 年美國關稅對供應鏈、定價策略和多重檢測全球合作的多方面影響

隨著美國新關稅將於2025年初生效，多重檢測供應鏈中的企業正在適應關鍵零件和成品進口關稅的提高。依賴專用光學元件和微流體晶片的儀器製造商被迫重新評估籌資策略，而耗材供應商則面臨著成本上漲的衝擊，這將波及到其分銷網路。為此，一些公司正在與海外供應商重新談判契約，探索替代製造地，並加快組裝業務的本地化。

透過詳細的產品類型、檢測方式、應用重點和最終用戶細分來解讀市場動態，從而發現成長機會

對市場區隔進行詳細檢驗，可以揭示相關人員可以利用的不同價值池和績效需求，從而進行策略定位。依產品類型分類，磁珠、微孔盤和試劑/試劑套件等耗材可提供經常性收益來源，補充流式細胞儀、螢光檢測系統、發光讀數儀和質譜儀等儀器的資本投資。同時，服務涵蓋從檢測開發、數據分析到樣品檢測的各個領域，每項服務都透過快速的周轉時間和深厚的技術專長提供差異化機會，而軟體和分析工具則透過安全的資料管理和高度連接複用的面板設計，為整個工作流程提供支援。

分析美洲、歐洲、中東和非洲以及亞太地區多重檢測格局的促進因素和障礙

區域分析揭示了美洲、中東和非洲以及亞太地區不同的成長動力和競爭挑戰。在美洲，強勁的轉化研究資金和成熟的受託研究機構基礎正在推動對高度多元化平台的需求。北美市場的監管協調進一步簡化了產品核可和上市後監管流程，使供應商能夠縮短新型檢測方法和設備的上市時間。

產業領導者的分析突顯了多重分析中的策略舉措、合作和競爭優勢

多重檢測領域的主要企業正透過對平台整合、策略夥伴關係以及超越其核心產品的服務能力的投入來脫穎而出。一些知名的儀器製造商正在與試劑供應商合作，提供垂直整合的解決方案，將其硬體的精度與其專有的檢測化學方法相結合。這種協作方式透過增強效能檢驗並提供針對每個平台最佳化的合格耗材，簡化了客戶的工作流程。

為行業領導者提供可行的策略建議，以利用技術趨勢並引領市場發展

為了抓住多重檢測領域的發展勢頭，產業領導者應優先整合模組化平台架構，以適應新興的檢測模式和可自訂的檢測化學方法。採用開放平台標準，企業能夠建構更廣泛的第三方試劑和軟體擴展生態系統，從而加快創新週期，縮短新應用的上市時間。

揭示 Multiplex Assay Insights 資料收集、檢驗和分析框架所依據的嚴謹調查方法

本報告採用定性和定量相結合的調查方法，對多重檢測市場進行了全面而全面的分析。與關鍵意見領袖和專家進行的初步探索性訪談，揭示了技術發展、競爭趨勢和監管挑戰的背景。這些見解為設計結構化問卷提供了參考，該問卷分發給主要地區的儀器製造商、耗材供應商、服務供應商和最終用戶的代表性樣本。

對塑造多重檢測未來的市場趨勢、技術進步和策略挑戰的綜合見解

在平台整合、工作流程微型化和進階資料分析整合的推動下，多重偵測領域可望持續創新。區域動態凸顯了將產品開發和上市策略與特定地區的監管要求、資金籌措重點和製造能力相結合的重要性。同時，2025 年的關稅變化也強化了對供應鏈敏捷性和協作採購模式的需求。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章市場動態

  • 整合人工智慧和機器學習來分析和解釋高維多重檢測數據
  • 開發可攜式POC 多重診斷裝置，用於快速檢測新興感染疾病變異株
  • 擴展高重空間蛋白質體多重分析以表徵腫瘤學中的腫瘤微環境
  • 採用微流體實驗室晶片多工平台，能夠以最小的樣品量進行超靈敏分析
  • 用於臨床微生物學中抗菌素抗藥性基因同時檢測的多重PCR板的開發
  • 以微珠為基礎的流式細胞技術檢測的出現，可用於 CAR-T 細胞療法監測中的全面免疫分析
  • 加強檢測開發商與生物製藥公司之間的合作，以實現精準醫療檢測中的多重伴隨診斷
  • 液態生物檢體分析中稀疏突變組絕對定量數位液滴多重PCR系統的實現

第6章 市場洞察

  • 波特五力分析
  • PESTEL分析

第7章 2025年美國關稅的累積影響

8. 多重分析市場（依產品類型）

  • 耗材
    • 珠子和探針
    • 微孔盤
    • 試劑和套件
  • 裝置
    • 流式細胞儀
    • 螢光檢測系統
    • 夜光閱讀器
    • 質譜儀
  • 服務
    • 檢測開發服務
    • 數據分析服務
    • 樣品測試服務
  • 軟體和分析工具

9. 多重檢測市場（依檢測類型）

  • 基於細胞的多重分析
  • 基於核酸的多重檢測
  • 基於蛋白質的多重檢測

第 10 章：多重分析市場（按應用）

  • 臨床診斷
    • 自體免疫疾病的診斷
    • 心血管疾病檢測
    • 傳染病檢查
    • 腫瘤學
  • 環境測試
  • 食品安全檢測
  • 研究與開發
    • 生物標記檢驗
    • 藥物研發
    • 基因組學研究
    • 蛋白質體學調查

第 11 章：多重分析市場（依最終使用者）

  • 學術研究機構
  • 合約研究組織（CRO）
  • 診斷實驗室
  • 醫院
  • 製藥和生物技術公司

12. 美國多重檢測市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

13. 歐洲、中東和非洲多重檢測市場

  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 阿拉伯聯合大公國
  • 沙烏地阿拉伯
  • 南非
  • 丹麥
  • 荷蘭
  • 卡達
  • 芬蘭
  • 瑞典
  • 奈及利亞
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波蘭
  • 瑞士

14. 亞太多重檢測市場

  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 印尼
  • 泰國
  • 菲律賓
  • 馬來西亞
  • 新加坡
  • 越南
  • 台灣

第15章競爭格局

  • 2024年市場佔有率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Abbott Laboratories
    • Abcam Limited by Danaher Corporation
    • Agilent Technologies, Inc.
    • Antigenix America, Inc.
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories, Inc.
    • Bio-Techne Corporation
    • Cayman Chemical Company
    • Charles River Laboratories International, Inc.
    • Enfer Group
    • Enzo Life Sciences, Inc.
    • Flagship Biosciences Inc.
    • Future Diagnostics Solutions BV
    • Gnome Diagnostics & Gnome Sciences
    • Illumina, Inc.
    • Merck KGaA
    • MESO SCALE DIAGNOSTICS, LLC
    • Novatein Biosciences Inc.
    • Protavio Ltd.
    • Siemens Healthineers AG
    • Solis BioDyne OU
    • Thermo Fisher Scientific Inc.

第16章 研究人工智慧

第17章 研究統計

第18章 研究聯絡人

第19章 研究報導

第20章 附錄

Product Code: MRR-8201ABF20BB9

The Multiplex Assays Market was valued at USD 2.81 billion in 2024 and is projected to grow to USD 3.10 billion in 2025, with a CAGR of 10.67%, reaching USD 5.16 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 2.81 billion
Estimated Year [2025] USD 3.10 billion
Forecast Year [2030] USD 5.16 billion
CAGR (%) 10.67%

Positioning Multiplex Assays Within the Modern Analytical Landscape Driven by Innovation in Platform Integration and Performance Optimization

Multiplex assays have emerged as a cornerstone technology in bioanalytical and diagnostic workflows, enabling simultaneous detection of multiple analytes within a single sample matrix. As researchers and clinicians demand more comprehensive data sets in less time, platforms that integrate advanced detection modalities with automated analysis pipelines are rapidly gaining prominence. Driven by the convergence of microfluidics, nanotechnology, and high-throughput instrumentation, the field now supports applications ranging from cytokine profiling in immunotherapy trials to pathogen screening in point-of-care diagnostics.

Furthermore, the push toward personalized medicine and precision health has intensified the need for multiplex solutions that deliver high sensitivity and specificity without sacrificing throughput. Consequently, manufacturers and service providers are investing in next-generation assay development services, robust data analysis software, and scalable instruments capable of meeting diverse research and clinical requirements. In this context, stakeholders must navigate a complex interplay of regulatory guidelines, quality standards, and emerging intellectual property considerations.

This report offers a foundational overview of the multiplex assay ecosystem, mapping out key technologies, stakeholder dynamics, and innovation drivers. By synthesizing primary interviews with industry experts and secondary data from reputable scientific literature, it provides a holistic view of current capabilities and future directions. The introduction sets the stage for an in-depth exploration of transformative shifts, tariff impacts, segmentation insights, and strategic recommendations that will follow.

Unveiling the Key Transformative Shifts Reshaping the Multiplex Assay Arena Through Integration, Miniaturization, and Data Analytics

The multiplex assay market is undergoing a profound evolution characterized by three interrelated dynamics: platform convergence, miniaturization, and enhanced data analytics. Initially, assay developers focused on standalone detection technologies, but recent trends favor integrated platforms that combine fluorescence, luminescence, and mass spectrometry. This shift enables laboratories to consolidate workflows, reduce sample consumption, and accelerate time to result by leveraging complementary detection modalities on a single instrument.

In parallel, the push for miniaturization-driven by the rise of lab-on-a-chip architectures-has transformed assay throughput and cost structures. These microfluidic devices facilitate the parallel processing of hundreds to thousands of microscale reactions, significantly lowering reagent volumes and enabling rapid iteration in assay development. As a result, research and development teams can deploy complex multiplex panels with unprecedented speed and precision, bolstering innovation in areas such as biomarker validation and drug candidate screening.

Moreover, the integration of advanced data analytics, including machine learning algorithms and cloud-based platforms, is reshaping how multiplex data sets are processed and interpreted. Real-time quality control metrics and predictive analytics now inform decision-making across sample preparation, assay execution, and data reporting. Taken together, these transformative shifts are redefining assay performance benchmarks and empowering stakeholders to address increasingly intricate research and clinical challenges.

Evaluating the Multifaceted Effects of US Tariff Policies Enacted in 2025 on Supply Chains, Pricing Strategies, and Global Collaboration in Multiplex Assays

With the introduction of new tariff measures by the United States in early 2025, companies within the multiplex assay supply chain are adapting to a landscape of elevated import duties on critical components and finished goods. Instrument manufacturers reliant on specialized optics and microfluidic chips have experienced pressure to reevaluate sourcing strategies, while consumables suppliers face cost increases that reverberate through distribution networks. In response, some organizations are renegotiating contracts with overseas suppliers, exploring alternative manufacturing hubs, and accelerating the localization of assembly operations.

These adjustments have led to a recalibration of pricing strategies, with several providers opting to absorb a portion of incremental costs to preserve market share while implementing tiered pricing models for different customer segments. Concurrently, collaborative partnerships have emerged as a mechanism to mitigate tariff-driven disruptions, enabling shared investments in regional production facilities and joint sourcing consortia that leverage collective bargaining power.

Despite these challenges, the policy changes have also stimulated greater supply chain resilience and transparency. Companies have intensified due diligence efforts to map component origins and ensure compliance with trade regulations. In turn, end users benefit from enhanced visibility into product provenance and risk profiles. Thus, the cumulative impact of the 2025 tariff environment has catalyzed a strategic realignment across the multiplex assay ecosystem, balancing cost optimization with a renewed focus on supply chain agility.

Decoding Market Dynamics Through Detailed Product Type, Assay Modality, Application Focus, and End User Segmentation to Identify Growth Opportunities

A granular examination of market segmentation reveals distinct value pools and performance requirements that stakeholders can leverage for strategic positioning. By product type, consumables such as beads and probes, microplates, and reagents and kits constitute a recurring revenue stream that complements the capital investments in instruments including flow cytometers, fluorescence detection systems, luminescence readers, and mass spectrometers. Meanwhile, services range from assay development and data analysis to sample testing, each offering opportunities for differentiation through rapid turnaround times and deep technical expertise, while software and analysis tools underpin the entire workflow by enabling secure data management and advanced multiplex panel design.

Assay type segmentation highlights the diversity of methodological approaches, with cell-based multiplex assays catering to immunophenotyping and functional studies, nucleic acid-based methods addressing high-throughput genotyping and transcript profiling, and protein-based multiplex assays optimized for cytokine quantification and biomarker discovery. This breadth of modalities illustrates how application requirements dictate platform selection, driving competition among providers to deliver specialized reagent kits and customizable protocols.

In application segmentation, clinical diagnostics spans autoimmune disease diagnosis, cardiovascular testing, infectious disease screening, and oncology, whereas environmental testing and food safety emphasize regulatory compliance and contamination monitoring. Research and development applications, including biomarker validation, drug discovery and development, genomics research, and proteomics research, demand high sensitivity and rigorous reproducibility, prompting collaborations between academic institutes and contract research organizations. End users range from academic and research institutes to CROs, diagnostic laboratories, hospitals, and pharmaceutical and biotechnology companies, each segment exhibiting unique procurement cycles and quality benchmarks.

Analyzing Regional Drivers and Barriers Across the Americas, Europe Middle East & Africa, and Asia-Pacific in the Multiplex Assay Landscape

Regional analysis uncovers divergent growth drivers and competitive challenges across the Americas, Europe Middle East & Africa, and Asia-Pacific. In the Americas, strong funding for translational research and an established base of contract research organizations fuel demand for advanced multiplex platforms. Regulatory harmonization across North American markets further streamlines product approvals and post-market surveillance, allowing suppliers to achieve faster time-to-market for novel assays and instruments.

Meanwhile, the Europe Middle East & Africa region is characterized by a dual focus on public health initiatives and academic research partnerships. European nations prioritize precision diagnostics within national healthcare strategies, creating incentives for multiplex assay adoption in clinical settings. In contrast, emerging markets in the Middle East and Africa are driven by collaborations between government agencies and private research foundations to enhance capabilities in infectious disease surveillance and environmental monitoring.

Asia-Pacific represents a rapidly expanding frontier, where domestic manufacturing ecosystems in countries such as China, India, and South Korea are scaling production of consumables, instruments, and service offerings. Government-led innovation grants and growing investments in biotechnology clusters have also elevated the region's role as both a consumer and producer of multiplex assay technologies. Collectively, these regional insights illustrate how localized factors shape competitive landscapes and investment priorities within the global multiplex assay market.

Profiling Leading Industry Players to Highlight Strategic Initiatives, Collaborative Ventures, and Competitive Differentiators in Multiplex Assays

Leading companies in the multiplex assay arena are distinguished by their investments in platform integration, strategic partnerships, and service capabilities that extend beyond core product offerings. Some prominent instrument manufacturers have forged alliances with reagent suppliers to deliver vertically integrated solutions, combining hardware precision with proprietary assay chemistries. This collaborative approach enhances performance validation and simplifies customer workflows by providing prequalified consumables optimized for each platform.

Service-oriented organizations are differentiating themselves by offering end-to-end assay development and data analysis packages, which leverage in-house bioinformatics teams and high-throughput screening facilities. By bundling these services with software licenses for multiplex panel design, they create integrated solutions that accelerate time-to-insight for research and clinical programs.

Additionally, several players are focusing on licensing agreements and joint ventures to expand geographic reach and tap into localized expertise, particularly in regions where regulatory landscapes require nuanced market entry strategies. Investments in digital interfaces, cloud connectivity, and real-time analytics further reinforce competitive positioning by enabling remote monitoring, predictive maintenance, and seamless data sharing across global laboratory networks.

Through a combination of technological innovation, collaborative ecosystems, and customer-centric service models, these leading entities are defining the next generation of multiplex solutions and setting benchmarks for quality, reliability, and user experience.

Delivering Actionable Strategic Recommendations for Industry Leaders to Capitalize on Technological Trends and Navigate Market Evolution

To capitalize on the momentum within the multiplex assay space, industry leaders should prioritize the integration of modular platform architectures that accommodate emerging detection modalities and customizable assay chemistries. By adopting open-platform standards, organizations can foster a broader ecosystem of third-party reagents and software extensions, driving faster innovation cycles and reducing time-to-market for new applications.

Moreover, establishing co-development partnerships with academic institutions and contract research organizations will enable access to novel biomarkers and specialized sample matrices, enhancing assay relevance across diverse research and clinical domains. Collaborative consortia focused on standardizing data formats and quality control metrics can further strengthen confidence in multiplex data sets, facilitating regulatory acceptance and cross-laboratory comparability.

Supply chain resilience should also be addressed through multi-regional sourcing strategies and regional manufacturing hubs that mitigate the impact of trade disruptions. Investing in digital supply chain management tools will provide real-time visibility into component availability, lead times, and cost fluctuations, enabling proactive decision-making.

Finally, organizations must cultivate in-house analytics expertise by integrating machine learning and artificial intelligence capabilities into data interpretation workflows. Upskilling laboratory personnel in bioinformatics and data science will maximize the value extracted from multiplex platforms and support strategic initiatives in precision medicine, environmental monitoring, and food safety assurance.

Elucidating the Rigorous Research Methodology Underpinning the Data Collection, Validation, and Analytical Framework for Multiplex Assay Insights

The research underpinning this report combined qualitative and quantitative methodologies to ensure a robust and comprehensive analysis of the multiplex assay market. Initial exploratory interviews with key opinion leaders and subject matter experts provided context on technological developments, competitive dynamics, and regulatory challenges. These insights informed the design of structured questionnaires distributed to a representative sample of instrument manufacturers, consumables suppliers, service providers, and end users across major regions.

Secondary research efforts involved a thorough review of peer-reviewed journals, conference proceedings, patent filings, and corporate literature to validate product portfolios, technology roadmaps, and partnership networks. Publicly available trade data and regulatory filings were triangulated with proprietary databases to corroborate supply chain footprints and trade flow adjustments, especially in light of recent tariff changes.

Data synthesis employed rigorous validation protocols, including cross-verification of respondent inputs and consistency checks against historical trends. Advanced statistical techniques, such as cluster analysis and regression modeling, were utilized to interpret segmentation patterns and regional variations. Finally, findings were reviewed by an internal panel of industry analysts to ensure coherence, accuracy, and relevance to current decision-making frameworks.

Synthesizing Insights on Market Trends, Technological Advancements, and Strategic Imperatives Shaping the Future of Multiplex Assays

The multiplex assay landscape is poised for sustained innovation, driven by the convergence of platform integration, miniaturized workflows, and sophisticated data analytics. Regional dynamics underscore the importance of aligning product development and market entry strategies with localized regulatory requirements, funding priorities, and manufacturing capabilities. Meanwhile, the 2025 tariff shifts have reinforced the necessity of supply chain agility and collaborative sourcing models.

Segmentation analysis highlights the interplay between product offerings and end user needs, illustrating how tailored solutions-whether in clinical diagnostics, environmental testing, or research and development-can unlock new avenues for value creation. Leading companies that embrace open standards, foster co-development partnerships, and invest in bioinformatics expertise will be well positioned to capture emerging growth opportunities and establish defensible competitive moats.

In conclusion, industry participants must adopt a dual focus on technological excellence and operational resilience. By executing targeted strategies across platform innovation, regulatory alignment, and supply chain diversification, stakeholders can navigate a rapidly evolving market while delivering high-impact solutions that address critical global challenges in health, safety, and scientific discovery.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Integration of AI and machine learning for high-dimensional multiplex assay data analytics and interpretation
  • 5.2. Development of portable point-of-care multiplex diagnostics for rapid detection of emerging infectious disease variants
  • 5.3. Expansion of high-plex spatial proteomics multiplex assays for tumor microenvironment characterization in oncology
  • 5.4. Adoption of microfluidic lab-on-a-chip multiplex platforms enabling ultra-sensitive assays with minimal sample volumes
  • 5.5. Growth of multiplex PCR panels for simultaneous detection of antimicrobial resistance genes in clinical microbiology
  • 5.6. Emergence of bead-based multiplex flow cytometry assays for comprehensive immune profiling in CAR-T cell therapy research
  • 5.7. Increasing collaboration between assay developers and biopharma for multiplex companion diagnostics in precision medicine trials
  • 5.8. Implementation of digital droplet multiplex PCR systems for absolute quantification of sparse mutation panels in liquid biopsy analysis

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Multiplex Assays Market, by Product Type

  • 8.1. Introduction
  • 8.2. Consumables
    • 8.2.1. Beads & Probes
    • 8.2.2. Microplates
    • 8.2.3. Reagents & Kits
  • 8.3. Instruments
    • 8.3.1. Flow Cytometers
    • 8.3.2. Fluorescence Detection Systems
    • 8.3.3. Luminescence Readers
    • 8.3.4. Mass Spectrometers
  • 8.4. Services
    • 8.4.1. Assay Development Services
    • 8.4.2. Data Analysis Services
    • 8.4.3. Sample Testing Services
  • 8.5. Software & Analysis Tools

9. Multiplex Assays Market, by Assay Type

  • 9.1. Introduction
  • 9.2. Cell-Based Multiplex Assays
  • 9.3. Nucleic Acid-Based Multiplex Assays
  • 9.4. Protein-Based Multiplex Assays

10. Multiplex Assays Market, by Application

  • 10.1. Introduction
  • 10.2. Clinical Diagnostics
    • 10.2.1. Autoimmune Disease Diagnosis
    • 10.2.2. Cardiovascular Disease Testing
    • 10.2.3. Infectious Disease Testing
    • 10.2.4. Oncology
  • 10.3. Environmental Testing
  • 10.4. Food Safety Testing
  • 10.5. Research & Development
    • 10.5.1. Biomarker Validation
    • 10.5.2. Drug Discovery & Development
    • 10.5.3. Genomics Research
    • 10.5.4. Proteomics Research

11. Multiplex Assays Market, by End User

  • 11.1. Introduction
  • 11.2. Academic & Research Institutes
  • 11.3. Contract Research Organizations (CROs)
  • 11.4. Diagnostic Laboratories
  • 11.5. Hospitals
  • 11.6. Pharmaceutical & Biotechnology Companies

12. Americas Multiplex Assays Market

  • 12.1. Introduction
  • 12.2. United States
  • 12.3. Canada
  • 12.4. Mexico
  • 12.5. Brazil
  • 12.6. Argentina

13. Europe, Middle East & Africa Multiplex Assays Market

  • 13.1. Introduction
  • 13.2. United Kingdom
  • 13.3. Germany
  • 13.4. France
  • 13.5. Russia
  • 13.6. Italy
  • 13.7. Spain
  • 13.8. United Arab Emirates
  • 13.9. Saudi Arabia
  • 13.10. South Africa
  • 13.11. Denmark
  • 13.12. Netherlands
  • 13.13. Qatar
  • 13.14. Finland
  • 13.15. Sweden
  • 13.16. Nigeria
  • 13.17. Egypt
  • 13.18. Turkey
  • 13.19. Israel
  • 13.20. Norway
  • 13.21. Poland
  • 13.22. Switzerland

14. Asia-Pacific Multiplex Assays Market

  • 14.1. Introduction
  • 14.2. China
  • 14.3. India
  • 14.4. Japan
  • 14.5. Australia
  • 14.6. South Korea
  • 14.7. Indonesia
  • 14.8. Thailand
  • 14.9. Philippines
  • 14.10. Malaysia
  • 14.11. Singapore
  • 14.12. Vietnam
  • 14.13. Taiwan

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Abbott Laboratories
    • 15.3.2. Abcam Limited by Danaher Corporation
    • 15.3.3. Agilent Technologies, Inc.
    • 15.3.4. Antigenix America, Inc.
    • 15.3.5. Becton, Dickinson and Company
    • 15.3.6. Bio-Rad Laboratories, Inc.
    • 15.3.7. Bio-Techne Corporation
    • 15.3.8. Cayman Chemical Company
    • 15.3.9. Charles River Laboratories International, Inc.
    • 15.3.10. Enfer Group
    • 15.3.11. Enzo Life Sciences, Inc.
    • 15.3.12. Flagship Biosciences Inc.
    • 15.3.13. Future Diagnostics Solutions B.V.
    • 15.3.14. Gnome Diagnostics & Gnome Sciences
    • 15.3.15. Illumina, Inc.
    • 15.3.16. Merck KGaA
    • 15.3.17. MESO SCALE DIAGNOSTICS, LLC
    • 15.3.18. Novatein Biosciences Inc.
    • 15.3.19. Protavio Ltd.
    • 15.3.20. Siemens Healthineers AG
    • 15.3.21. Solis BioDyne OU
    • 15.3.22. Thermo Fisher Scientific Inc.

16. ResearchAI

17. ResearchStatistics

18. ResearchContacts

19. ResearchArticles

20. Appendix

LIST OF FIGURES

  • FIGURE 1. MULTIPLEX ASSAYS MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 14. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 16. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. MULTIPLEX ASSAYS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 22. MULTIPLEX ASSAYS MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 23. MULTIPLEX ASSAYS MARKET: RESEARCHAI
  • FIGURE 24. MULTIPLEX ASSAYS MARKET: RESEARCHSTATISTICS
  • FIGURE 25. MULTIPLEX ASSAYS MARKET: RESEARCHCONTACTS
  • FIGURE 26. MULTIPLEX ASSAYS MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. MULTIPLEX ASSAYS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY BEADS & PROBES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY BEADS & PROBES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY MICROPLATES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY MICROPLATES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY FLOW CYTOMETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY FLOW CYTOMETERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY FLUORESCENCE DETECTION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY FLUORESCENCE DETECTION SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY LUMINESCENCE READERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY LUMINESCENCE READERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY MASS SPECTROMETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY MASS SPECTROMETERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY DEVELOPMENT SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY DEVELOPMENT SERVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY DATA ANALYSIS SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY DATA ANALYSIS SERVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY SAMPLE TESTING SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY SAMPLE TESTING SERVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY SOFTWARE & ANALYSIS TOOLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY SOFTWARE & ANALYSIS TOOLS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY CELL-BASED MULTIPLEX ASSAYS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY CELL-BASED MULTIPLEX ASSAYS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID-BASED MULTIPLEX ASSAYS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID-BASED MULTIPLEX ASSAYS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN-BASED MULTIPLEX ASSAYS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN-BASED MULTIPLEX ASSAYS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY AUTOIMMUNE DISEASE DIAGNOSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY AUTOIMMUNE DISEASE DIAGNOSIS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY CARDIOVASCULAR DISEASE TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY CARDIOVASCULAR DISEASE TESTING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 65. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 67. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY ENVIRONMENTAL TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY ENVIRONMENTAL TESTING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 69. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY FOOD SAFETY TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY FOOD SAFETY TESTING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 71. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 73. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY BIOMARKER VALIDATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY BIOMARKER VALIDATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 75. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 77. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY GENOMICS RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY GENOMICS RESEARCH, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 79. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY PROTEOMICS RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY PROTEOMICS RESEARCH, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 81. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
  • TABLE 83. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 85. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 87. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 89. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 91. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 93. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 95. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 96. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 97. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 98. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 99. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 100. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 101. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 102. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 103. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
  • TABLE 104. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
  • TABLE 105. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 106. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 107. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 108. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 109. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
  • TABLE 110. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
  • TABLE 111. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 112. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 113. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 115. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 116. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 117. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 118. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 119. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 120. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 121. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 122. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 123. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
  • TABLE 124. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
  • TABLE 125. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 126. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 127. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 128. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 129. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
  • TABLE 130. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
  • TABLE 131. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 132. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 133. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 134. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 135. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 136. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 137. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 138. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 139. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 140. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 141. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 142. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 143. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
  • TABLE 144. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
  • TABLE 145. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 146. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 147. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 148. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 149. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
  • TABLE 150. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
  • TABLE 151. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 152. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 153. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 154. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 155. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 156. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 157. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 158. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 159. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 160. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 161. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
  • TABLE 162. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
  • TABLE 163. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 164. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 165. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 166. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 167. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
  • TABLE 168. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
  • TABLE 169. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 170. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 171. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 172. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 173. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 174. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 175. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 176. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 177. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 178. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 179. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
  • TABLE 180. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
  • TABLE 181. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 182. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 183. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 184. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 185. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
  • TABLE 186. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
  • TABLE 187. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 188. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 189. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 190. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 191. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 192. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 193. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 194. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 195. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 196. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 197. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
  • TABLE 198. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
  • TABLE 199. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 200. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 201. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 202. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 203. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
  • TABLE 204. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
  • TABLE 205. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 206. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 227. UNITED KINGDOM MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. UNITED KINGDOM MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 230. UNITED KINGDOM MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 232. UNITED KINGDOM MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 234. UNITED KINGDOM MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. UNITED KINGDOM MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 238. UNITED KINGDOM MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 239. UNITED KINGDOM MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 240. UNITED KINGDOM MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 241. UNITED KINGDOM MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
  • TABLE 242. UNITED KINGDOM MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
  • TABLE 243. UNITED KINGDOM MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. UNITED KINGDOM MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 245. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 246. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 247. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 248. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 249. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 250. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 251. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 252. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 253. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
  • TABLE 255. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 256. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 257. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 258. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 259. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
  • TABLE 260. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
  • TABLE 261. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 262. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 263. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 265. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 266. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 267. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 268. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 269. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 270. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 271. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
  • TABLE 273. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 274. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 275. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 276. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 277. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
  • TABLE 278. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
  • TABLE 279. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 280. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 281. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 282. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 283. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 284. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 285. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 286. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 287. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 288. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 289. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
  • TABLE 291. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 292. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 293. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 294. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 295. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
  • TABLE 296. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
  • TABLE 297. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 298. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 299. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 300. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 301. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 302. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 303. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 304. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 305. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 306. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 307. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
  • TABLE 308. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
  • TABLE 309. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 310. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 311. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 312. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 313. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
  • TABLE 314. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
  • TABLE 315. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 316. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 317. SPAIN MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 318. SPAIN MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 319. SPAIN MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 320. SPAIN MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 321. SPAIN MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 322. SPAIN MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 323. SPAIN MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 324. SPAIN MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 325. SPAIN MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
  • TABLE 326. SPAIN MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
  • TABLE 327. SPAIN MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 328. SPAIN MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 329. SPAIN MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 330. SPAIN MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 331. SPAIN MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
  • TABLE 332. SPAIN MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
  • TABLE 333. SPAIN MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 334. SPAIN MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 335. UNITED ARAB EMIRATES MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 336. UNITED ARAB EMIRATES MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 337. UNITED ARAB EMIRATES MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 338. UNITED ARAB EMIRATES MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 339. UNITED ARAB EMIRATES MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 340. UNITED ARAB EMIRATES MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 341. UNITED ARAB EMIRATES MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 342. UNITED ARAB EMIRATES MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 343. UNITED ARAB EMIRATES MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
  • TABLE 344. UNITED ARAB EMIRATES MULT